期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血浆B型钠尿肽与心脏肌钙蛋白T在非ST段抬高型急性冠状动脉综合征诊断及预后的评估价值 被引量：3

Estimated value of plasma BNP and cTnT in diagnosis and prognosis of non-ST-segment elevation acute coronary syndrome
暂未订购
导出
摘要 目的探讨血浆B型钠尿肽(BNP)与心脏肌钙蛋白T(cTnT)在非ST段抬高型急性冠状动脉综合征(NSTE-ACS)诊断及预后评估价值。方法选择2004年1月至2012年1月该院收治的NSTE-ACS患者286例,BNP≥80pg/mL患者172例为A组,BNP<80pg/mL患者114例为B组,比较两组患者的临床资料。结果 A组入院即刻、6、12、24、48h的血清BNP、血浆cTnT水平高于B组(P<0.05)。结论在临床中结合cTnT和BNP水平检测,可应用于NSTE-ACS患者诊断和预后的判断。 Objective To explore the diagnostic and prognostic value of plasma B-type natriuretic peptide（BNP） and cardiac troponin T（cTnT） in non-ST elevation acute coronary syndrome（NSTE-ACS）.Methods 286 patients with NSTE-ACS in this hospital from January 2004 to January 2011 were selected and divided into two groups,172 cases of plasma BNP≥80 pg/mL as the group A and 114 cases of plasma BNP80 pg/mL as the group B.The clinical data were compared between the two groups.Results Plasma BNP and serum cTnT immediately after admission,at 6,12,24,48 h in the group A were higher than those in the group B（P0.05）.Conclusion Combined detection of plasma BNP and cTnT in clinic can be used to judge the diagnosis and prognosis of NSTE-ACS.
作者 兰世才 田维淮
机构地区 重庆市万盛经济开发区人民医院内二科
出处 《重庆医学》 CAS CSCD 北大核心 2013年第9期1029-1030,1032,共3页 Chongqing medicine
关键词 冠状动脉疾病 心肌肌钙蛋白T B型钠尿肽 coronary artery disease cardiac troponin T B-type natriuretic peptide
分类号 R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献14

  • 1Fazlinezhad A, Rezaeian MK, Yousefzadeh H, et al. Plas ma brain natriuretic peptide(BNP) as an indicator of left ventricular function, early outcome and mechanical com- plications after acute myocardial infarction[J]. Clin Med Insights Cardiol, 2011,5 : 77-83.
  • 2Manola S,Pavlovic N,Radebic V,et al. Btype natriuretic peptide as predictor of heart failure in patients with acute ST elevation myocardial infarction, single-vessel disease, and complete revascularization: follow-up study[J]. Croat Med J,2009,50(5) :449-454.
  • 3Eggers KM, Lagerqvist B, Venge P, et al. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome[J]. J Am Coll Cardiol,2009,54 (4) :357-364.
  • 4Leon de la Fuente R,Naesgaard PA, Nilsen ST, et al. B type natriuretic peptide and high sensitive C-reactive pro- tein predict 2 year all cause mortality in chest pain pa- tients: a prospective observational study from Salta, Ar- gentina[J]. BMC Cardiovasc Disord, 2011,11 : 57.
  • 5Alpert JS, Thygesen K, Antman E, et al. Myocardial in- farction redefined-a consensus document of The Joint Eu ropean Society of Cardiology/American College of Cardi- ology Committee for the redefinition of myocardial infarc- tion[J].J Am Coll Cardiol,2000,36(3):959 969.
  • 6Hall TS, H allen J, Agewall S, et al. Changes in diagnosing non-ST-segment elevation myocardial infarction after the introduction of a new high-sensitivity cardiac troponin T assay : a single centre experience[J]. Clin Lab, 2012,58 ( 9/ 10) : 1029-1036.
  • 7Perna ER, Aspromonte N, Cimbaro Canella JP, et al. Mi nor myocardial damage is a prevalent condition in patients with acute heart failure syndromes and preserved systolic function with long-term prognostic implications. A report from the CIAST-HF (Collaborative halo-Argentinean Study on cardiac troponin T in heart failure) study[J]. J Card Fail,2012,18(11) :822-830.
  • 8De Lemos JA, Morrow DA, Bentley JH, et al. The prog nostic value of B-type natriuretic peptide in patients with acute coronary syndromes[J]. N Engl J Med, 2001, 345 (14):1014-1021.
  • 9Morrow DA,De Lemos JA,Sabatine MS,et al. Evaluation of B-type natriuretic peptide for risk assessment in unsta- ble angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18 [J]. J Am Coll Cardiol,2003,41 (8) : 1264-1272.
  • 10张志成,宋阳.cTnT、MYO和CK-MBmass对AMI的诊断价值[J].重庆医学,2004,33(8):1163-1165. 被引量：13

二级参考文献15

  • 1杨振华.应考虑在缺血性心脏病使用一些新的生化标记物[J].中华心血管病杂志,1997,25(5):327-327.
  • 2Panteghni M,Apple FS,Christenson RH,et al.Proposal from IFFCC committee on Standadization of Markers of Cardiac Damage(C-CD): recommendation on use of biochemical markers of cardiac damage in acute coronary syndromes [J].Scand J Clinic Lab Invest,1999,59
  • 3Wu AH,Apple FS,Gilbert WB,et al.National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendation on use of biochemical markers of cardiac damage in acute coronary syndromes [J].Clin Chem,1999,45:1104
  • 4Alpert JS,Thygesen K,Antman E,et al.Myocardial infarction redefined: a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction[J].J Am Coll Cardiol,2000,36: 959
  • 5Christenson RH,Azzazy HME.Biochemical markers of the acute coronary syndromes[J].Clin Chem,1998,44 (11): 1855
  • 6Wu AHB.Biochemical markers of cardiac damage: from traditional enzymes to cardiac-specific proteins [J].Scand J Clin Lab Invest,1999,59(Supple 230): 74
  • 7Khan IA,Tun A,Wattanasauwan N,et al.Elevation of serum cardiac troponin T in non cardiac and cardiac diseases other than acute coronary syndrome[J].An J Emerg Med,1999,17:225
  • 8Wu ABH,Apple FS,Gibler,et al.National academy of clinical Biochemistry standards of laboratory practice.Recommendations for the use of cardiac markets in coronary artery diseases[J].Clin Chem,1999,45:1104
  • 9Gerhardt W,Katus HA,Ravkilde J,et al.S-troponin T in suspected ischemic myocardial injury compared with mass and catelytic concentration of S-creatine kinase isoenzyme[J].Clin Chem,1991,37: 1405
  • 10Christenson RH,Apple FS.Cardiac troponin I measurement on the ACCESS immunoassay system: analytical and clinical performance characteristics[J].Clin Chem,1998,44 (2): 494

共引文献12

同被引文献30

引证文献3

二级引证文献14

重庆医学
2013年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部